168 related articles for article (PubMed ID: 25790916)
1. Platelet function in patients with a history of unexplained recurrent miscarriage who subsequently miscarry again.
Dempsey MA; Flood K; Burke N; Murray A; Cotter B; Mullers S; Dicker P; Fletcher P; Geary M; Kenny D; Malone FD
Eur J Obstet Gynecol Reprod Biol; 2015 May; 188():61-5. PubMed ID: 25790916
[TBL] [Abstract][Full Text] [Related]
2. Platelet reactivity and pregnancy loss.
Flood K; Peace A; Kent E; Tedesco T; Dicker P; Geary M; Malone FD; Kenny D
Am J Obstet Gynecol; 2010 Sep; 203(3):281.e1-5. PubMed ID: 20684942
[TBL] [Abstract][Full Text] [Related]
3. Viable pregnancies beyond 28 weeks gestation in women with a history of unexplained recurrent miscarriage have reduced platelet function.
Dempsey MA; Flood K; Burke N; Murray A; Cotter B; Muellers S; Dicker P; Fletcher P; Geary M; Malone FD; Kenny D
Eur J Obstet Gynecol Reprod Biol; 2016 May; 200():76-81. PubMed ID: 26994466
[TBL] [Abstract][Full Text] [Related]
4. Time to conception and time to live birth in women with unexplained recurrent miscarriage.
Kaandorp SP; van Mens TE; Middeldorp S; Hutten BA; Hof MH; van der Post JA; van der Veen F; Goddijn M
Hum Reprod; 2014 Jun; 29(6):1146-52. PubMed ID: 24682612
[TBL] [Abstract][Full Text] [Related]
5. Non-visualized pregnancy losses are prognostically important for unexplained recurrent miscarriage.
Kolte AM; van Oppenraaij RH; Quenby S; Farquharson RG; Stephenson M; Goddijn M; Christiansen OB;
Hum Reprod; 2014 May; 29(5):931-7. PubMed ID: 24603132
[TBL] [Abstract][Full Text] [Related]
6. Perinatal outcomes of women with a prior history of unexplained recurrent miscarriage.
Dempsey MA; Flood K; Burke N; Fletcher P; Kirkham C; Geary MP; Malone FD
J Matern Fetal Neonatal Med; 2015 Mar; 28(5):522-5. PubMed ID: 24824106
[TBL] [Abstract][Full Text] [Related]
7. Could platelet distribution width be a predictive marker for unexplained recurrent miscarriage?
Mete Ural U; Bayoğlu Tekin Y; Balik G; Kir Şahin F; Colak S
Arch Gynecol Obstet; 2014 Aug; 290(2):233-6. PubMed ID: 24619190
[TBL] [Abstract][Full Text] [Related]
8. Midluteal serum progesterone concentration does not predict the outcome of pregnancy in women with unexplained recurrent miscarriage.
Yan J; Liu F; Yuan X; Saravelos SH; Cocksedge K; Li TC
Reprod Biomed Online; 2013 Feb; 26(2):138-41. PubMed ID: 23273755
[TBL] [Abstract][Full Text] [Related]
9. Prothrombotic state of patients with unexplained recurrent spontaneous abortion.
Lu X; Liu Z; Zhang X; Kang X; Shen W; Zhao A
Int J Gynaecol Obstet; 2015 Nov; 131(2):161-5. PubMed ID: 26296564
[TBL] [Abstract][Full Text] [Related]
10. Platelet aggregation abnormalities in patients with recurrent fetal losses.
Beyan C; Kaptan K; Ifran A
Thromb Res; 2007; 121(3):327-31. PubMed ID: 17555805
[TBL] [Abstract][Full Text] [Related]
11. The relationship between serum prolactin concentration and pregnancy outcome in women with unexplained recurrent miscarriage.
Li W; Ma N; Laird SM; Ledger WL; Li TC
J Obstet Gynaecol; 2013 Apr; 33(3):285-8. PubMed ID: 23550860
[TBL] [Abstract][Full Text] [Related]
12. Platelet reactivity changes significantly throughout all trimesters of pregnancy compared with the nonpregnant state: a prospective study.
Burke N; Flood K; Murray A; Cotter B; Dempsey M; Fay L; Dicker P; Geary MP; Kenny D; Malone FD
BJOG; 2013 Dec; 120(13):1599-604. PubMed ID: 23924249
[TBL] [Abstract][Full Text] [Related]
13. Perinatal outcomes in a subsequent pregnancy among women who have experienced recurrent miscarriage: a retrospective cohort study.
Field K; Murphy DJ
Hum Reprod; 2015 May; 30(5):1239-45. PubMed ID: 25759495
[TBL] [Abstract][Full Text] [Related]
14. Thyroid peroxidase antibody in women with unexplained recurrent miscarriage: prevalence, prognostic value, and response to empirical thyroxine therapy.
Yan J; Sripada S; Saravelos SH; Chen ZJ; Egner W; Li TC
Fertil Steril; 2012 Aug; 98(2):378-82. PubMed ID: 22624672
[TBL] [Abstract][Full Text] [Related]
15. Levels of thrombin-activatable fibrinolysis inhibitor and platelet-activating factor in recurrent pregnancy loss patients.
Eser A; Inegol Gumus I; Erdamar H; Kaygusuz I; Yildirim M; Usluogullari B; Duran Erdolu M; Simavli SA; Yigitoglu R; Ozturk Turhan N
Taiwan J Obstet Gynecol; 2016 Feb; 55(1):60-3. PubMed ID: 26927250
[TBL] [Abstract][Full Text] [Related]
16. Arachidonic acid-induced platelet aggregation and acetylsalicylic acid treatment during pregnancy in women with recurrent miscarriage, a post hoc study.
Blomqvist LRF; Strandell AM; Jeppsson A; Hellgren MSE
Platelets; 2022 Feb; 33(2):278-284. PubMed ID: 33646930
[TBL] [Abstract][Full Text] [Related]
17. The prevalence and impact of fibroids and their treatment on the outcome of pregnancy in women with recurrent miscarriage.
Saravelos SH; Yan J; Rehmani H; Li TC
Hum Reprod; 2011 Dec; 26(12):3274-9. PubMed ID: 21954281
[TBL] [Abstract][Full Text] [Related]
18. Aetiology of recurrent miscarriage and the role of adjuvant treatment in its management: a retrospective cohort review.
Dobson SJA; Jayaprakasan KM
J Obstet Gynaecol; 2018 Oct; 38(7):967-974. PubMed ID: 29557233
[TBL] [Abstract][Full Text] [Related]
19. Cervical fetal fibronectin as a predictor of first trimester pregnancy outcome in unexplained recurrent miscarriage.
Mercorio F; Mercorio A; Di Spiezio Sardo A; Votino C; Barba GV; Nappi C
Eur J Obstet Gynecol Reprod Biol; 2006 Jun; 126(2):165-9. PubMed ID: 16256259
[TBL] [Abstract][Full Text] [Related]
20. Gestational age of pregnancy loss in women with unexplained recurrent miscarriage.
Ticconi C; Giuliani E; Sorge R; Patrizi L; Piccione E; Pietropolli A
J Obstet Gynaecol Res; 2016 Mar; 42(3):239-45. PubMed ID: 26663368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
